Apotheken | Arzt | Interaktionen | Medikamente | MiGeL | Services | Spital | Zulassungsi.
Fachinformation zu Trawell® Tabletten:MEDA Pharma GmbH
Vollst. FachinformationDDDDrucken 
Fahrtücht.Unerw.WirkungenÜberdos.Eigensch.Pharm.kinetikPräklin.Sonstige H.Swissmedic-Nr.
Reg.InhaberStand d. Info. 
A04AD - Other AntiemeticsATC-DDD Version 2016. Source: WHO
A - Alimentary Tract and Metabolism
A04 - Antiemetics and Antinauseants
A04A - Antiemetics and Antinauseants

Antihistamines, which are often used as antiemetics, are classified in R06 - Antihistamines for systemic use.
Metoclopramide is classified in A03FA.
Combinations with analgesics are classified in N02 - Analgesics.
Antivertigo preparations, see N07C.
Antipsychotics, see N05A.

A04AD - Other Antiemetics

Fosaprepitant, a prodrug of aprepitant, is classified together with the parent drug in A04AD12.
Droperidol used for prevention of nausea and vomiting is classified in N05AD.

The DDD for scopolamine plaster is one plaster (i.e. 1 UD). This DDD is based on prophylaxis of motion sickness.
DDDs for other substances classified in this group are based on antiemetic treatment.
The DDDs for aprepitant/fosaprepitant (A04AD12) are based on treatment with 165 mg tablets/150 mg injection given as a single dose on day one of the treatment regimen. The DDD for rolapitant is also based on the single dose treatment on day one of the treatment regimen.

2024 ©ywesee GmbH
Einstellungen | Hilfe | FAQ | Anmeldung | Kontakt | Home